Lab Test

Mycoplasma genitalium PCR

Mycoplasma genitalium, mycoplasma, MG, MGen, STI

Test Codes

EPIC: LAB1230889, Beaker: ICMG

Department

Molecular Pathology

Instructions

Nucleic acid amplification testing (NAAT) is the preferred option for the detection of Mycoplasma genitalium (MG).  Swabs (vaginal or endocervical) in Alinity m Multi-collect media and urine in Alinity m Multi-collect media are acceptable for testing. 

Specimen Collection Criteria

Collect: Swabs or urine as described below:

SWABS: Vaginal (patient-collected or clinician-collected), endocervical (clinician-collected)

  • Note: Patient-collected vaginal samples must be collected in a healthcare setting
  • Collect swab in Alinity m Multi-collect media

URINE (Male or Female):  

Preferred specimen: First void urine in Alinity m Multi-collect media. To ensure specimen integrity, collecting locations should refrain from sending urine in sterile collection cups and should instead transfer urine into Alinity m Multi-Collect Media prior to transport.

Also acceptable: Midstream urine in an Alinity m multi-collect media tube. Midstream specimens have decreased clinical sensitivity and are of limited diagnostic value.

Urine Collection Instructions:

  1. First void ("dirty") urine is included in this collection, this is collected before a UA specimen, if both are needed.
  2. Do not cleanse the genital area prior to specimen collection.
  3. Patient should not have urinated for at least one hour prior to sample collection.
  4. Follow directions above to obtain a first void urine specimen.
  5. Discard specimen collection swab, it is not required for urine specimen collection.
  6. Unscrew the transport tube cap, taking care not to spill the transport buffer within.
  7. Handle the cap and tube carefully to avoid contamination.
  8. Use the plastic transfer pipette to transfer urine from the collection cup into the transport tube until the liquid level in the tube falls within the clear fill window of the transport tube label or else a new specimen should be collected.
  9. Do not overfill. Slightly more than one full squeeze of the transfer pipette bulb may be required to transfer the necessary volume of urine specimen.
  10. Recap the transport tube carefully. Ensure the cap seals tightly.
  11. Label the transport tube with sample identification information, including date of collection. Take care not to obscure the fill window on the transport tube.

Mycoplasma Genitalium PCR MUST be ordered at the time of collection.

Add-on tests CANNOT be performed on urine specimens following testing on other Instrumentation (i.e., urinalysis).

Physician Office/Draw Specimen Preparation

  • Swabs and urine collected in Alinity m Multi-collect media can be stored and transported at room temperature (20 to 26°C or 68 to 78.8°F) or refrigerated (2 to 8°C or 36 to 46°F)
  • If unpreserved urine is sent, samples must be refrigerated (2 to 8°C or 36 to 46°F) and must be transported to Alinity m Multi-Collect Media within 24 hours of collection. Samples beyond this stability will be rejected. To avoid this, it is recommended that the collecting location transfer urine from the sterile cup to the Alinity m Multi-Collect Media prior to transport.

Preparation for Courier Transport

Transport: Swabs and urine collected in Alinity m Multi-Collect Media can be stored and transported at room temperature (20 to 26°C or 68 to 78.8°F). Unpreserved/neat urine samples must be refrigerated (2 to 8°C or 36 to 46°F) and transported to Alinity m Multi-Collect Media within 24 hours of collection. Samples beyond this will be rejected.

Rejection Criteria

  • Unlabeled specimens.
  • Specimens submitted in transport media other than Alinity m multi-collect specimen collection media.
  • Urine specimens sent in a sterile container that were not refrigerated or have not been transferred to Alinity m Multi-Collect Media within 24 hours of collection.
  • SurePath or ThinPrep liquid-based cytology specimens.
  • Add-on requests for samples that have been previously run on other instrumentation.
  • Samples collected on patients <14 years of age.

Inpatient Specimen Preparation

Specimens should be sent to the main Laboratory if received at Royal Oak. Specimens received at other campuses must be added to a packing list before being sent to Royal Oak Laboratory. 

Storage

Abbott Alinity m Multi-collect specimens- Urines, swabs (Vaginal or Endocervical
Room Temperature (20-26°C or 68-78.8°F): 14 days
Refrigerated (2-8°C or 36-46°F): 14 days
Frozen (-20°C/-4°F or below): 60 days

Unpreserved / Neat Urine Specimens
Refrigerated (2-8°C or 36-46°F): 24 hours
Frozen (-20°C/-4°F or below): Unacceptable

Specimen Storage in Department Prior to Disposal:

Alinity m Multi-collect urines and swabs): Room Temperature (20-26°C or 68-78.8°F) for 7 days

Unpreserved / Neat Urine Specimens: Refrigerated (2-8°C or 36-46°F) for 7 days

Laboratory

Royal Oak Molecular Pathology Laboratory

Performed

Monday – Saturday
Results are usually available within 24-48 hours of receipt in the Laboratory (excluding weekends and holidays).

Reference Range

Mycoplasma genitalium PCR not detected.

Test Methodology

Nucleic acid amplification testing was performed using the FDA-cleared Abbott Alinity m STI assay (Abbott Alinity m System).

Interpretation

By report.

Clinical Utility

Mycoplasma genitalium (MG) is a fastidious bacterium first isolated in 1980 from the urethral swabs of two symptomatic men with non-gonococcal urethritis (NGU). Infections caused by this bacterium have been associated with male and female urethritis, balanoposthitis, prostatitis, cervicitis, pelvic inflammatory disease, and female infertility. Additional complications, such as preterm delivery and extra-genital infections, have been reported. There have been few studies showing an accurate prevalence of MG, because historically this bacterium is difficult to culture. However, several molecular assays have been described that show a prevalence as high as 47.5%. More recent studies using nucleic acid testing showed an MG prevalence of 16-17% in females, with a higher rate of detection observed in vaginal swabs. Another study showed that 8.1% of males who presented to a public sexual health clinic had MG detected in their urine.

Men with recurrent NGU should be tested for M. genitalium using an FDA-cleared NAAT. Women with recurrent cervicitis should be tested for M. genitalium, and testing should be considered among women with PID. Screening of asymptomatic M. genitalium infection among women and men or extragenital testing for M. genitalium is not recommended. In clinical practice, if testing is unavailable, M. genitalium should be suspected in cases of persistent or recurrent urethritis or cervicitis and considered for PID.

Reference

  1. Package insert, Alinity m STI AMP Kit. Revised August 2023: Abbott Molecular, Inc. Ref 09N17-095. 53-608012/R3
  2. Sexually Transmitted Infections Guidelines, 2021. Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm

CPT Codes

87563

Contacts

Last Updated

3/17/2025

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.